In support of PDE5 inhibitors’ ability to affect prostate carcinogensis, it was reported that exisulind suppressed the growth of metastatic, human prostate cancer cells in a nude mouse xenograft model by increasing apoptosis [214]. The gene discussed is PDE5A; the disease is prostate carcinoma.